Genflow Biosciences Expands Confidentiality Deals for Gene Therapy Program Data Review

MT NewswiresApr 28 18:01

Jingfang Medicine-B (02595.HK) clarifies: The entities, products, and disputed matters mentioned in the letter issued by Rev Med are unrelated to the company.

Gelonghui, April 28th: Juntai Pharmaceutical-B (02595.HK) announced that the company has recently noted several reports involving Revolution Medicines Inc. (“RevMed”) issuing letters to third-party companies regarding disputes over RAS inhibitor patents and trade secrets. The company hereby clarifies and emphasizes: the entities, products, and disputed matters mentioned in the letters issued by RevMed are unrelated to the company. Juntai’s Pan RAS inhibitor GFH276 possesses fully independent and original intellectual property rights, with no similar infringement or trade secret issues.

Gelonghui FinanceApr 28 12:34

Hong Kong Stock Market Midday Review | Hang Seng Index fell 0.20% in the morning session, semiconductor sector bucked the trend with gains

The semiconductor sector of the US stock market performed remarkably well overnight, with the Philadelphia Semiconductor Index rising for 17 consecutive trading days. Semiconductor stocks in the Hong Kong stock market surged against the broader trend.

Zhitong FinanceApr 24 12:00

H-share Movement | Jinfang Medicine-B (02595) rose over 3% as two preclinical studies of GFH375/VS-7375 were selected for breakthrough research abstracts.

Jing Fang Medicine-B (02595) rose over 3%. As of the time of writing, it had increased by 3.4%, trading at HKD 46.8 with a transaction volume of HKD 15.9244 million.

Zhitong FinanceApr 24 10:35

H-share Movement | Jinfang Pharmaceuticals-B (02595) rose nearly 6% before noon after the company announced preclinical research data for its pan-RAS inhibitor GFH276.

JingFang Medicine-B (02595) rose nearly 6% in the morning session. As of the time of writing, it was up 4.45%, trading at HKD 45.96, with a turnover of HKD 19.7838 million.

Zhitong FinanceApr 22 11:38

GENFLEET-B: 2025 Annual Report

HKEXApr 17 22:40 · Announcements